# Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer

> **NCT00078832** · PHASE3 · COMPLETED · sponsor: **Queen Mary University of London** · enrollment: 3864 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** anastrozole
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00078832
- **Lead sponsor:** Queen Mary University of London
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2013-12
- **Final completion:** 2021-05-31
- **Target enrollment:** 3864 (ACTUAL)
- **Last updated:** 2021-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00078832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00078832, "Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00078832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*